The Clorox Company (NYSE:CLX) Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC cut its holdings in shares of The Clorox Company (NYSE:CLX) by 20.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,466 shares of the company’s stock after selling 1,443 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Clorox were worth $890,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Insight Folios Inc grew its stake in shares of Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the period. Fiduciary Group LLC raised its position in shares of Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after buying an additional 72 shares during the last quarter. GHP Investment Advisors Inc. lifted its stake in Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares in the last quarter. SPC Financial Inc. lifted its position in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after buying an additional 75 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its holdings in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after buying an additional 75 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Evercore ISI reduced their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. DA Davidson raised their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. JPMorgan Chase & Co. upped their price objective on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by insiders.

Clorox Stock Up 0.6 %

Shares of NYSE:CLX opened at $167.34 on Wednesday. The firm has a market capitalization of $20.71 billion, a PE ratio of 58.31, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm’s 50-day moving average is $162.84 and its two-hundred day moving average is $148.88.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. Analysts predict that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.